My Size, INC

My Size, Inc. announced the results of its 2026 annual meeting, with shareholders approving director elections, executive compensation advisory vote, and a reverse stock split authorization, while rejecting a blank check preferred stock amendment.

MySize, Inc. announced first quarter 2026 results, showcasing a 62% year-over-year revenue increase to $2.39 million and a significant improvement in gross margin to 39.3%.

My Size, Inc. received a notice from Nasdaq regarding non-compliance with the minimum $1.00 bid price requirement, initiating a 180-day compliance period.

MySize, Inc. announced estimated preliminary financial results for 2025, projecting $10 million in revenue and outlining a path to $15 million in 2026, driven by its integrated AI-driven sizing and commerce platform.

My Size, Inc. announced its Compensation Committee approved restricted stock awards for executive officers under its 2017 Equity Incentive Plan.

MySize, Inc. announced strong third-quarter 2025 financial results, featuring sequential revenue growth and margin expansion driven by its global technology platforms and European secondhand marketplace.

My Size, Inc. reported a 62% increase in revenue for Q1 2026 to $2.39 million, but also saw an expanded net loss of $1.48 million.

My Size, Inc. reported a net loss of $1.335 million for Q3 2025, alongside strategic acquisitions of ShoeSizeMe and New Percentil, while facing substantial doubt about its ability to continue as a going concern.

My Size, Inc. reported a reduced net loss in Q2 2025, driven by lower operating expenses and financial income, despite a significant revenue decrease for the six-month period, while also acquiring resale platform Percentil.

My Size, Inc. reports a decrease in revenue for Q1 2025, driven by lower Orgad sales, as the company focuses on commercializing its Naiz Fit technology and integrating recent acquisitions.

My Size, Inc. reported increased revenue for the nine months ended September 30, 2024, but also recorded a significant goodwill impairment charge impacting overall profitability.

My Size, Inc. saw a significant increase in revenue during the second quarter of 2024, primarily driven by its Orgad e-commerce platform, but continues to face substantial doubt about its ability to continue as a going concern.

My Size, Inc. filed its annual report detailing a net loss of $5.85 million for 2025, while highlighting strategic acquisitions and growth initiatives in fashion technology.

MySize, Inc. reports its financial results for the fiscal year ended December 31, 2024, outlining its growth strategy, recent acquisitions, and financial performance.

MySize Inc. reported its full year 2023 results, highlighting increased revenue and a strategic focus on commercializing its Naiz Fit platform.

My Size, Inc. CEO Ronen Luzon acquired 3,750 shares of common stock, signaling confidence in the company's future.

My Size, Inc. CEO Ronen Luzon reported the acquisition of 275,000 restricted common shares, including shares for his spouse, under the company's 2017 Equity Incentive Plan.

My Size, Inc. Director Oron Branitzky was granted 15,000 restricted shares of common stock, vesting on December 31, 2025.

My Size, Inc. Chief Financial Officer Oren Elmaliah was granted 30,000 restricted common shares under the company's 2017 Equity Incentive Plan.

My Size, Inc.'s Chief Growth Officer, Borja Cembrero Saralegui, was granted 110,000 restricted shares of common stock with various vesting conditions.

My Size, Inc.'s Chief Product and Operating Officer, Billy Pardo, and his spouse, CEO Ronen Luzon, were granted a total of 275,000 restricted shares under the company's 2017 Equity Incentive Plan.

My Size, Inc. announces its 2026 Annual Meeting of Stockholders, detailing proposals including a reverse stock split, director elections, and executive compensation approval.

My Size, Inc. has filed a definitive proxy statement with the U.S. Securities and Exchange Commission.

My Size, Inc. has issued its definitive proxy statement for its Annual Meeting on September 4, 2025, seeking shareholder approval for the re-election of two Class I directors, a substantial increase in its 2017 Equity Incentive Plan share reserve, and the adoption of an evergreen provision for future equity awards.

My Size, Inc. has filed a definitive proxy statement with the SEC.

My Size, Inc. will hold its annual meeting of stockholders on December 30, 2024, to elect a director and ratify the appointment of its independent public accountant.

My Size, Inc. is seeking stockholder approval for a reverse stock split at its upcoming special meeting to regain compliance with Nasdaq's minimum bid price requirement.

My Size, Inc. CEO Ronen Luzon and CPO Billy Pardo increased their combined beneficial ownership to 8.02% through restricted stock grants and open market purchases.